AR076982A1 - DERIVADOS DE ARIL-{4-HALOGENO-4-[AMINOMETIL]-PIPERIDIN-1-IL}-METANONA, SU PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN - Google Patents
DERIVADOS DE ARIL-{4-HALOGENO-4-[AMINOMETIL]-PIPERIDIN-1-IL}-METANONA, SU PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENENInfo
- Publication number
- AR076982A1 AR076982A1 ARP100101982A ARP100101982A AR076982A1 AR 076982 A1 AR076982 A1 AR 076982A1 AR P100101982 A ARP100101982 A AR P100101982A AR P100101982 A ARP100101982 A AR P100101982A AR 076982 A1 AR076982 A1 AR 076982A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogen
- branched
- group
- linear
- aminometil
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 101100450129 Caenorhabditis elegans hal-3 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000003709 fluoroalkyl group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicacion 1: Compuestos de formula general (1) en la que R1 representa: - un átomo de hidrogeno, o un halogeno, - un grupo alquilo en C1-6 lineal o ramificado, o un grupo fluoroalquilo en C1-3, - un grupo alcoxi en C1-6 lineal o ramificado, - un grupo carbamilo N-sustituido o no por uno o dos grupo(s) alquilo(s) en C1-3 lineal(es) o ramificado(s), o - un grupo ciano (CN). R2 representa: - un átomo de hidrogeno o un grupo alquilo en C1-6 lineal o ramificado Hal1, Hal2 y Hal3 representan: - un halogeno, sus sales de adicion y los hidratos de las sales de adicion con los ácidos minerales o los ácidos orgánicos farmacéuticamente aceptables, así como sus formas enantioméricas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0953725A FR2946344B1 (fr) | 2009-06-05 | 2009-06-05 | Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
AR076982A1 true AR076982A1 (es) | 2011-07-20 |
Family
ID=41328950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100101982A AR076982A1 (es) | 2009-06-05 | 2010-06-04 | DERIVADOS DE ARIL-{4-HALOGENO-4-[AMINOMETIL]-PIPERIDIN-1-IL}-METANONA, SU PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN |
Country Status (7)
Country | Link |
---|---|
US (1) | US8669250B2 (es) |
EP (1) | EP2438050B9 (es) |
JP (1) | JP5657649B2 (es) |
AR (1) | AR076982A1 (es) |
FR (1) | FR2946344B1 (es) |
TW (1) | TW201100409A (es) |
WO (1) | WO2010139758A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681325B1 (fr) | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
FR2840900B1 (fr) * | 2002-06-18 | 2005-02-25 | Pf Medicament | Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments |
-
2009
- 2009-06-05 FR FR0953725A patent/FR2946344B1/fr not_active Expired - Fee Related
-
2010
- 2010-06-03 EP EP10724750.4A patent/EP2438050B9/en not_active Not-in-force
- 2010-06-03 WO PCT/EP2010/057781 patent/WO2010139758A1/en active Application Filing
- 2010-06-03 JP JP2012513626A patent/JP5657649B2/ja not_active Expired - Fee Related
- 2010-06-03 US US13/376,331 patent/US8669250B2/en not_active Expired - Fee Related
- 2010-06-04 AR ARP100101982A patent/AR076982A1/es unknown
- 2010-06-04 TW TW099118161A patent/TW201100409A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
FR2946344A1 (fr) | 2010-12-10 |
US8669250B2 (en) | 2014-03-11 |
TW201100409A (en) | 2011-01-01 |
WO2010139758A1 (en) | 2010-12-09 |
EP2438050B9 (en) | 2014-04-23 |
EP2438050B1 (en) | 2013-08-07 |
JP5657649B2 (ja) | 2015-01-21 |
US20120115860A1 (en) | 2012-05-10 |
FR2946344B1 (fr) | 2012-05-25 |
JP2012528833A (ja) | 2012-11-15 |
EP2438050A1 (en) | 2012-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP11010912A (es) | Compuestos de pirrol | |
CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
PE20151781A1 (es) | Piridonamidas como moduladores de canales de sodio | |
AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
CO6430425A2 (es) | Compuestos en calidad de antagonistas de bradiquinina b1 | |
CR10662A (es) | Compuestos de metilpiridopirimidinona | |
AR075892A1 (es) | Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
ECSP099781A (es) | Novedosos compuestos que son inhibidores de erk | |
ECSP109922A (es) | Compuestos de pirazol y su uso como inhibidores raf | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CO6531496A2 (es) | Amidas sustituidas con halógenoalquilo como insecticidas y acaricidas | |
CO6351780A2 (es) | Nuevas benzamidas, su preparaccion y su uso como medicamentos | |
CR20140217A (es) | Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas ii | |
PE20141380A1 (es) | Imidazopiridazinas como inhibidores de quinasa akt | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
SV2011003944A (es) | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexano de ccr2 | |
CO6331335A2 (es) | Nuevos compuestos antagonistas de los receptores b1 de bradiquinina | |
ECSP10010105A (es) | Antagonistas de cgrp | |
UY33565A (es) | Compuestos de tetrahidrofuranilo disustituidos como antagonistas de bradiquinina-B1 | |
ES2606839T3 (es) | Tetraaza-ciclopenta[a]indenilo y su uso como moduladores alostéricos positivos | |
DOP2010000393A (es) | Derivados de dibenzotiazepina y sus usos | |
CY1107193T1 (el) | Παραγωγα πιπεραζινης και η χρηση τους ως αναστολεων της επανασυλληψης της σεροτονινης ή ως ανταγωνιστων της νευροκινινης | |
EA200900944A1 (ru) | Новый способ получения кристаллической формы v агомелатина |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |